These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27341339)

  • 1. Relative Contribution of Dengue IgG Antibodies Acquired during Gestation or Breastfeeding in Mediating Dengue Disease Enhancement and Protection in Type I Interferon Receptor-Deficient Mice.
    Lee PX; Ong LC; Libau EA; Alonso S
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004805. PubMed ID: 27341339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage.
    Martínez Gómez JM; Ong LC; Lam JH; Binte Aman SA; Libau EA; Lee PX; St John AL; Alonso S
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004536. PubMed ID: 27007501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies.
    Ng JK; Zhang SL; Tan HC; Yan B; Martinez JM; Tan WY; Lam JH; Tan GK; Ooi EE; Alonso S
    PLoS Pathog; 2014 Apr; 10(4):e1004031. PubMed ID: 24699622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.
    Lam JH; Chua YL; Lee PX; Martínez Gómez JM; Ooi EE; Alonso S
    JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
    Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
    J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention.
    Goncalvez AP; Engle RE; St Claire M; Purcell RH; Lai CJ
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9422-7. PubMed ID: 17517625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection.
    Wang Y; Si L; Luo Y; Guo X; Zhou J; Fang D; Yan H; Zeng G; Jiang L
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9685-98. PubMed ID: 26219500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
    Lau L; Green AM; Balmaseda A; Harris E
    J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
    Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T
    Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants.
    Castanha PM; Braga C; Cordeiro MT; Souza AI; Silva CD; Martelli CM; van Panhuis WG; Nascimento EJ; Marques ET
    J Infect Dis; 2016 Jul; 214(2):265-72. PubMed ID: 27056951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.
    Fink AL; Williams KL; Harris E; Alvine TD; Henderson T; Schiltz J; Nilles ML; Bradley DS
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005721. PubMed ID: 28686617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models.
    Tang WW; Grewal R; Shresta S
    Curr Opin Virol; 2015 Aug; 13():61-6. PubMed ID: 26001278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.
    Acosta EG; Bartenschlager R
    Expert Rev Vaccines; 2016; 15(4):467-82. PubMed ID: 26577689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA.
    Moi ML; Lim CK; Kotaki A; Takasaki T; Kurane I
    J Virol Methods; 2010 Feb; 163(2):205-9. PubMed ID: 19781573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors.
    Mady BJ; Erbe DV; Kurane I; Fanger MW; Ennis FA
    J Immunol; 1991 Nov; 147(9):3139-44. PubMed ID: 1680925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal Immunity and Vaccination Influence Disease Severity in Progeny in a Novel Mast Cell-Deficient Mouse Model of Severe Dengue.
    Mantri CK; Soundarajan G; Saron WAA; Rathore APS; Alonso S; St John AL
    Viruses; 2021 May; 13(5):. PubMed ID: 34066286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model.
    Kyle JL; Balsitis SJ; Zhang L; Beatty PR; Harris E
    Virology; 2008 Oct; 380(2):296-303. PubMed ID: 18774583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice.
    Zellweger RM; Eddy WE; Tang WW; Miller R; Shresta S
    J Immunol; 2014 Oct; 193(8):4117-24. PubMed ID: 25217165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.
    Tang CT; Liao MY; Chiu CY; Shen WF; Chiu CY; Cheng PC; Chang GJ; Wu HC
    PLoS One; 2015; 10(8):e0136328. PubMed ID: 26309127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.